Overview
MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension
Status:
Completed
Completed
Trial end date:
1993-02-01
1993-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The study had a 4 week single blind placebo period followed by 12 weeks of double blind treatment. Patients were randomized to one of four treatment arms to evaluate the antihypertensive efficacy of Losartan.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Losartan
Criteria
Inclusion Criteria:- Patient has been diagnosed with mild to moderate hypertension
- Patient has no treatment or active medical problem, other than hypertension that might
affect the patients blood pressure
Exclusion Criteria:
- Pregnant of lactating female patients
- Secondary hypertension or history of malignant hypertension
- Sitting systolic blood pressure > 210 mmHg
- History of stroke
- History of myocardial infarction with in the past year
- Current of prior history of heart failure
- Known hypersensitivity to losartan
- Obesity
- Patients known to be HIV positive or known to be positive for Hepatitis B
- Absence of one kidney
- Patient is abusing or previously abused alcohol or drugs with in past two years